Up a level |
Drozd-Sokolowska, Joanna ORCID: 0000-0002-4562-6264, Gras, Luuk, Zinger, Nienke, Zahrani, Mohsen Al, Passweg, Jakob, Byrne, Jenny, Ho, Aloysius, Huang, Xiao-jun, Kroeger, Nicolaus, Mayer, Jiri, Russo, Domenico, De Becker, Ann, Tbakhi, Abdelghani, Stamatoullas, Aspasia, Valerius, Thomas, Hayden, Patrick ORCID: 0000-0003-1374-4503, McLornan, Donal P., Onida, Francesco, Scheid, Christof, Robin, Marie and Yakoub-Agha, Ibrahim . Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant.. LONDON: SPRINGERNATURE. ISSN 1476-5365
Kroeger, Nicolaus, Brand, Ronald, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Weber, Thomas, Robin, Marie, Stelljes, Matthias, Afanasiev, Boris V., Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Gramatzki, Martin, Bethge, Wolfgang A., Poire, Xavier, Kobbe, Guido, van Os, Marleen, Iacobelli, Simona and de Witte, Theo (2014). Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kroeger, Nicolaus, Iacobelli, Simona, Franke, Georg-Nikolaus, Platzbecker, Uwe, Uddin, Ruzena, Huebel, Kai, Scheid, Christof, Weber, Thomas, Robin, Marie ORCID: 0000-0003-1388-9876, Stelljes, Matthias, Afanasyev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco ORCID: 0000-0002-2991-3474, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa ORCID: 0000-0002-9731-8335, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Brand, Ronald and de Witte, Theo (2017). Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). J. Clin. Oncol., 35 (19). S. 2157 - 2167. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kroeger, Nicolaus, Iacobelli, Simona, Koster, Linda, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Scheid, Christoph, Weber, Thomas, Stelljes, Matthias, Afanasiev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Yakoub-Agha, Ibrahim and Robin, Marie (2018). Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Nabergoj, Mitja ORCID: 0000-0003-2842-3198, Mauff, Katya, Beelen, Dietrich, Ganser, Arnold ORCID: 0000-0003-3510-4304, Kroeger, Nicolaus, Stoelzel, Friedrich, Finke, Juergen, Passweg, Jakob, Cornelissen, Jan, Schub, Natalie, Veelken, Joan Hendrik, Beguin, Yves, Wilson, Keith, Zuckerman, Tsila, Hunault-Berger, Mathilde, Lioure, Bruno, Porras, Rocio Parody, Turlure, Pascal, Kerre, Tessa, Koster, Linda, Hayden, Patrick J., Onida, Francesco, Scheid, Christof, Chalandon, Yves, Robin, Marie and Yakoub-Agha, Ibrahim (2022). Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant., 57 (7). S. 1072 - 1079. LONDON: SPRINGERNATURE. ISSN 1476-5365